Industry ‘Deeply Concerned’ Over Slow Progress With EU Drug Authentication System

Pharmaceutical industry stakeholders are “deeply concerned” about the slow rate of sign-ups to the future European medicines authentication system, according to the industry federation EFPIA. To encourage more companies to connect as early as possible, the joining fee is to increase this month. There are also wider worries about EU member state implementation of the system.